Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Integra LifeSciences Acquires Rebound Therapeutics - Orthopedic Design & Technology
Financial/Business, OEM News

Integra LifeSciences Acquires Rebound Therapeutics

Adds minimally invasive platform for neurosurgery.

Integra LifeSciences Holdings Corporation, a leading global medical technology company, has acquired Rebound Therapeutics, developers of single-use medical devices that enable minimally invasive access, using optics and illumination, for visualization, diagnostic and therapeutic use in neurosurgery. Rebound’s minimally invasive surgical (MIS) technology features integrated optics and illumination capable of interfacing with existing operating room monitors.
 
“The acquisition of Rebound Therapeutics reflects Integra’s ongoing commitment to developing innovative products to address unmet needs in neurosurgery,” said Dan Reuvers, corporate vice president and president of Integra LifeSciences’ Codman Specialty Surgical division. “Rebound’s MIS technological platform is a natural addition to our portfolio of neurosurgical products and will expand our therapeutic-focused offerings. We are eager to further develop Rebound’s cutting-edge MIS technologies to help surgeons improve the standard of care for neurosurgery patients.”
 
“Integra has a strong track record of commercializing technologies and working with surgeons to advance surgical care,” said Jeff Valko, chief executive officer, Rebound Therapeutics. “Through its global neurosurgical sales team, we are looking forward to providing both surgeons and patients with greater access to our products.”
 
Integra LifeSciences does not expect this acquisition to have a material financial impact in 2019.

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters